GO:0005838 proteasome regulatory particle: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005838 (proteasome regulatory particle) is a multisubunit complex that caps the proteasome core particle and recognizes, unfolds, and translocates ubiquitinated proteins into the core for degradation.
• The regulatory particle is also known as the 19S regulatory particle, PA700, or the modulator complex, and it consists of a lid and a base subcomplex.
• Its base contains ATPases (Rpt1-6) and ubiquitin receptors (Rpn1, Rpn10, Rpn13), while the lid contains deubiquitinating enzymes such as PSMD14/Rpn11.
• Assembly of the regulatory particle is a highly ordered process involving chaperones and multiple intermediate complexes.
• Dysregulation of the regulatory particle is implicated in cancer, especially multiple myeloma, where PSMD14 drives myelomagenesis via histone deubiquitination.
• Studying GO:0005838 requires integrated structural, biochemical, and genetic approaches, including CRISPR knockout, point mutation, and knock-in models.
Description
The proteasome regulatory particle (GO:0005838) is a multisubunit complex that caps one or both ends of the proteasome core complex. It recognizes and unfolds ubiquitinated proteins and translocates them into the core complex for degradation. This regulatory particle is essential for the specificity and efficiency of the ubiquitin-proteasome system, which controls the turnover of most cellular proteins and regulates processes such as cell cycle progression, apoptosis, and immune response. The regulatory particle is also known as the 19S regulatory particle, PA700, or the modulator complex, reflecting its role in modulating proteasome activity. Researchers study GO:0005838 to understand how substrate recognition, deubiquitination, unfolding, and translocation are coordinated, and how defects in these steps contribute to human diseases including cancer and neurodegeneration. The regulatory particle has been a focus of structural biology, with cryo-electron microscopy revealing its architecture and conformational dynamics. Small-molecule inhibitors targeting the regulatory particle are being developed as therapeutic agents, particularly for cancers that depend on proteasome activity. Thus, GO:0005838 represents a central node in protein homeostasis and a promising target for drug discovery.
proteasome regulatory particle At A Glance
| GO ID | GO:0005838 |
|---|---|
| GO term | proteasome regulatory particle |
| Ontology | cellular_component |
| Synonym | 19S regulatory particle; modulator complex; PA700-dependent proteasome activator; PA700 proteasome activator |
| Major function | Recognizes, unfolds, and translocates ubiquitinated proteins to the proteasome core complex for degradation |
| Subunits | Base (Rpt1-6, Rpn1, Rpn2, Rpn10, Rpn13) and lid (Rpn3, Rpn5-9, Rpn11/PSMD14, Rpn12, Sem1) |
| Assembly | Ordered assembly with chaperones and intermediate complexes |
| Disease relevance | Cancer (e.g., multiple myeloma), neurodegeneration |
| Research methods | Cryo-EM, CRISPR knockout, point mutation, knock-in, proteomics |
What Is GO:0005838?
The proteasome regulatory particle is a multisubunit protein complex that binds to one or both ends of the proteasome core complex (also known as the 20S core particle). Its primary function is to recognize proteins that have been tagged with ubiquitin chains, unfold them, and translocate them into the core complex where they are degraded into short peptides. The regulatory particle is often called the 19S regulatory particle because of its sedimentation coefficient, or PA700 for its ability to activate the 20S core in an ATP-dependent manner. It is composed of two main subcomplexes: the base, which contains ATPases and ubiquitin receptors, and the lid, which contains deubiquitinating enzymes and scaffolding proteins. This complex is essential for the ATP-dependent degradation of ubiquitinated proteins and for various cellular processes including cell cycle control, stress response, and antigen presentation.
Why Is proteasome regulatory particle Important in Cell Biology?
The proteasome regulatory particle (GO:0005838) is crucial because it provides the specificity and regulation of the ubiquitin-proteasome system, which degrades most cellular proteins and controls virtually every cellular process. Without the regulatory particle, the 20S core particle cannot efficiently degrade ubiquitinated proteins, leading to accumulation of damaged or misfolded proteins and disruption of signaling pathways. The regulatory particle is also a validated drug target: inhibitors such as bortezomib and carfilzomib target the core particle, but small-molecule inhibitors of the regulatory particle are being developed to overcome resistance and improve selectivity. Moreover, mutations or dysregulation of regulatory particle subunits are linked to cancer, particularly multiple myeloma, where PSMD14 (Rpn11) promotes myelomagenesis through histone deubiquitination. Understanding the regulatory particle's structure, assembly, and mechanism is therefore essential for basic cell biology and for developing new therapeutics.
• Controls the degradation of ubiquitinated proteins, regulating cell cycle, apoptosis, and stress responses.
• Its base ATPases unfold substrates and translocate them into the 20S core, a unique mechanical function.
• The lid deubiquitinating enzyme PSMD14/Rpn11 removes ubiquitin chains before degradation, recycling ubiquitin.
• Assembly of the regulatory particle is a highly ordered process with chaperones, and its disruption causes proteasome deficiency.
• Dysregulation of regulatory particle subunits is implicated in cancer, especially multiple myeloma.
• Small-molecule inhibitors targeting the regulatory particle are promising anticancer agents.
• Structural studies by cryo-EM have revealed conformational changes during substrate processing.
• The regulatory particle is involved in antigen presentation and immune response.
• Mutations in regulatory particle genes can cause neurodegeneration and developmental disorders.
• CRISPR-based models (KO, point mutation, knock-in) are essential to dissect subunit functions.
What Happens During proteasome regulatory particle?
Substrate Recognition and Binding
In simple terms: The regulatory particle grabs onto proteins that have been tagged with ubiquitin chains.
The base subcomplex of the regulatory particle contains ubiquitin receptors such as Rpn1, Rpn10, and Rpn13 that bind to polyubiquitin chains on substrate proteins. This initial recognition is essential for selectivity and is regulated by the length and linkage type of the ubiquitin chain. The lid subunit Rpn11 (PSMD14) also contributes to substrate binding and positioning.
Deubiquitination
In simple terms: Before the protein is fed into the core, the regulatory particle removes the ubiquitin tags so they can be reused.
The lid contains the metalloprotease Rpn11 (PSMD14), which cleaves ubiquitin chains from substrates prior to translocation. This deubiquitination step is coupled to ATP hydrolysis and ensures that ubiquitin molecules are recycled. PSMD14 also has histone deubiquitinase activity, linking it to chromatin regulation and myelomagenesis.
Unfolding and Translocation
In simple terms: The regulatory particle uses ATP to unfold the protein and push it into the core for destruction.
The six AAA+ ATPases (Rpt1-6) in the base form a ring that unfolds substrates and translocates them into the 20S core particle. This process is ATP-dependent and involves conformational changes in the ATPase ring. The unfolded polypeptide is threaded through a narrow pore into the core's catalytic chamber.
Degradation and Release
In simple terms: Once inside the core, the protein is chopped into small pieces, and the regulatory particle resets for another round.
The 20S core particle degrades the unfolded protein into short peptides, which are then released. The regulatory particle dissociates from the core or remains bound for multiple rounds of degradation. ATP hydrolysis also drives the release of peptides and the resetting of the complex.
Key Genes Involved in GO:0005838 proteasome regulatory particle
The proteasome regulatory particle is composed of numerous subunits encoded by distinct genes, each with specific roles in substrate recognition, deubiquitination, unfolding, and assembly.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSMD14 (Rpn11) | Lid deubiquitinase; removes ubiquitin chains; histone deubiquitinase | Oncogenic driver in multiple myeloma; drug target |
| PSMC1 (Rpt2) | Base ATPase; unfolds and translocates substrates | Essential for proteasome activity; knockout lethal |
| PSMC2 (Rpt1) | Base ATPase; part of the ATPase ring | Mutations affect substrate processing |
| PSMC3 (Rpt5) | Base ATPase; interacts with ubiquitin receptors | Target for small-molecule inhibitors |
| PSMC4 (Rpt3) | Base ATPase; ATP-dependent unfolding | Required for cell cycle progression |
| PSMC5 (Rpt6) | Base ATPase; translocates substrates | Phosphorylation regulates activity |
| PSMC6 (Rpt4) | Base ATPase; ring component | Assembly chaperone interactions |
| PSMD1 (Rpn2) | Base scaffold; binds ubiquitin receptors | Structural core of base |
| PSMD2 (Rpn1) | Base ubiquitin receptor; binds polyubiquitin | Recognizes ubiquitinated substrates |
| PSMD4 (Rpn10) | Ubiquitin receptor; binds K48-linked chains | Regulates substrate selection |
| ADRM1 (Rpn13) | Ubiquitin receptor; binds K48 chains | Potential cancer target |
| PSMD7 (Rpn8) | Lid subunit; interacts with Rpn11 | Required for deubiquitination |
| PSMD8 (Rpn12) | Lid subunit; assembly and stability | Mutations affect lid formation |
| PSMD11 (Rpn6) | Lid subunit; regulates assembly | Overexpression in cancer |
| PSMD12 (Rpn5) | Lid subunit; scaffold | Essential for lid integrity |
| PSMD13 (Rpn9) | Lid subunit; interacts with Rpn11 | Assembly intermediate |
| PSMD3 (Rpn3) | Lid subunit; substrate recruitment | Regulates proteasome activity |
| SEM1 (Rpn15) | Lid subunit; small acidic protein | Stabilizes lid complex |
How Is proteasome regulatory particle Regulated?
The proteasome regulatory particle is regulated at multiple levels, including transcriptional control of subunit genes, assembly chaperones, post-translational modifications, and ATP availability. For example, phosphorylation of Rpt6 (PSMC5) by protein kinases modulates proteasome activity. The assembly of the regulatory particle is tightly regulated by dedicated chaperones such as Pba1-Pba4, Rpn14, and Nas6, which ensure correct order of subunit incorporation. Additionally, the availability of ubiquitinated substrates and the activity of deubiquitinating enzymes like PSMD14 influence the overall rate of degradation. Small-molecule inhibitors can also modulate regulatory particle function, offering pharmacological control.
proteasome regulatory particle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSMD14 | Multiple myeloma; histone deubiquitination | Knockout and point mutation in myeloma cell lines |
| PSMD12 | Neurodevelopmental disorder | Knock-in mouse models |
| PSMC1 | Proteasome deficiency; cell cycle arrest | CRISPR knockout in cancer cells |
| ADRM1 | Cancer progression; ubiquitin receptor | Overexpression and knockout models |
| PSMD11 | Cancer; stem cell pluripotency | Knockdown and overexpression |
Multiple Myeloma and Cancer
Dysregulation of the proteasome regulatory particle is strongly linked to cancer, particularly multiple myeloma. PSMD14 (Rpn11) drives myelomagenesis through a histone deubiquitinase activity that alters chromatin and gene expression. Overexpression of regulatory particle subunits such as PSMD11 and PSMD14 is observed in various cancers and correlates with poor prognosis. Inhibitors targeting the regulatory particle are being developed to overcome resistance to core particle inhibitors like bortezomib.
Neurodegenerative Diseases
Impaired proteasome function, including regulatory particle dysfunction, contributes to the accumulation of misfolded proteins in neurodegenerative diseases such as Alzheimer's and Parkinson's. Mutations in regulatory particle subunits or assembly chaperones can lead to proteasome insufficiency and neuronal death. Enhancing regulatory particle activity is being explored as a therapeutic strategy.
Developmental Disorders
Mutations in genes encoding regulatory particle subunits or assembly factors can cause developmental disorders, including intellectual disability and growth retardation. For example, mutations in PSMD12 have been linked to a neurodevelopmental syndrome. These findings highlight the importance of the regulatory particle in development.
From proteasome regulatory particle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PSMD14 loss on myeloma growth? | CRISPR knockout of PSMD14 in multiple myeloma cell lines |
| How does a point mutation in PSMC1 affect ATPase activity? | Point mutation knock-in in HEK293 cells |
| What is the role of Rpn13 ubiquitin binding in substrate recognition? | Knock-in of ubiquitin-binding mutant |
| How does PSMD11 overexpression affect stem cell self-renewal? | Overexpression in induced pluripotent stem cells |
| What is the assembly pathway of the regulatory particle? | Tagged knock-in of Rpt subunits for affinity purification |
| Can small-molecule inhibitors selectively target the regulatory particle? | CRISPR knockout of resistance genes followed by drug treatment |
How to Study the proteasome regulatory particle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure and conformational dynamics | Visualizing regulatory particle architecture |
| Mass spectrometry | Protein interactions and modifications | Identifying subunit partners |
| CRISPR knockout | Gene function loss | Testing essentiality of subunits |
| Site-directed mutagenesis | Specific amino acid function | Dissecting ATPase or deubiquitinase activity |
| ATPase assay | ATP hydrolysis rate | Measuring base activity |
| Deubiquitination assay | Cleavage of ubiquitin chains | Testing Rpn11/PSMD14 activity |
| Peptide degradation assay | Proteolysis rate | Measuring coupled core-regulatory activity |
Structural Biology (Cryo-EM)
Cryo-electron microscopy has been used to determine the structure of the regulatory particle alone and in complex with the core particle, revealing conformational changes during substrate processing. These studies provide mechanistic insights into ATPase function and deubiquitination.
Proteomics and Mass Spectrometry
Affinity purification coupled with mass spectrometry identifies interacting partners and post-translational modifications of regulatory particle subunits. Quantitative proteomics can measure changes in subunit composition under different conditions.
Genetic Screens and CRISPR
CRISPR-based knockout, point mutation, and knock-in models are used to dissect the function of individual subunits in cells. Genome-wide CRISPR screens can identify genes that modulate sensitivity to regulatory particle inhibitors.
Biochemical Assays
In vitro assays using purified regulatory particle and core particle measure ATP hydrolysis, deubiquitination, and peptide degradation. These assays are used to test small-molecule inhibitors.
How CRISPR Can Be Used to Study GO:0005838 proteasome regulatory particle
Knockout
CRISPR knockout of regulatory particle subunit genes (e.g., PSMD14, PSMC1) is used to assess their essentiality and effects on cell viability, proteasome activity, and substrate accumulation. Knockout models help identify which subunits are required for cancer cell survival.
Point Mutation
Point mutations can be introduced into catalytic residues (e.g., the ATPase active site of PSMC1 or the deubiquitinase active site of PSMD14) to dissect specific functions without completely eliminating the protein. These models are valuable for understanding mechanism and drug resistance.
Knock-in
Knock-in of tagged versions (e.g., GFP, HA, or BirA) of regulatory particle subunits allows for live-cell imaging, affinity purification, and proximity labeling. Knock-in of disease-associated mutations can model human disorders.
Overexpression
Overexpression of regulatory particle subunits (e.g., PSMD11, PSMD14) is used to study their oncogenic potential and effects on proteasome activity and cellular transformation. Overexpression models can also reveal dominant-negative effects.
How EDITGENE Supports proteasome regulatory particle Research
Researchers studying proteasome regulatory particle-related genes often need to determine whether a candidate gene is causally involved in proteasome function, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for proteasome regulatory particle research.
Frequently Asked Questions About proteasome regulatory particle
What is the proteasome regulatory particle?
The proteasome regulatory particle (GO:0005838) is a multisubunit complex that caps the proteasome core particle, recognizes and unfolds ubiquitinated proteins, and translocates them into the core for degradation.
What genes are involved in the proteasome regulatory particle?
Key genes include PSMD14, PSMC1-6, PSMD1-4, PSMD7-13, ADRM1, and SEM1, encoding subunits of the base and lid subcomplexes.
What is the function of GO:0005838?
Its function is to recognize, deubiquitinate, unfold, and translocate ubiquitinated substrates into the 20S core particle for degradation.
How is the proteasome regulatory particle assembled?
Assembly is an ordered process involving chaperones and intermediate complexes, ensuring correct incorporation of base and lid subunits.
What diseases are associated with the proteasome regulatory particle?
Dysregulation is linked to multiple myeloma, other cancers, neurodegenerative diseases, and developmental disorders.
What is the difference between the 19S regulatory particle and the 20S core particle?
The 19S regulatory particle (GO:0005838) caps the 20S core particle, which contains the proteolytic active sites; the regulatory particle handles substrate recognition and unfolding.
How can CRISPR be used to study the proteasome regulatory particle?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of individual subunits and their roles in disease.
What are small-molecule inhibitors of the proteasome regulatory particle?
These are compounds that target the regulatory particle rather than the core, offering potential for overcoming resistance to traditional proteasome inhibitors.
What is PSMD14 and why is it important?
PSMD14 (Rpn11) is a lid deubiquitinase that removes ubiquitin chains and also has histone deubiquitinase activity; it drives myelomagenesis.
What methods are used to study the proteasome regulatory particle?
Cryo-EM, mass spectrometry, CRISPR screens, and biochemical assays are commonly used.
Conclusion
The proteasome regulatory particle (GO:0005838) is a central component of the ubiquitin-proteasome system, responsible for recognizing, unfolding, and translocating ubiquitinated proteins into the 20S core for degradation. Its intricate structure and assembly, involving base and lid subcomplexes, are critical for proteostasis and cellular regulation. Dysregulation of the regulatory particle contributes to cancer, neurodegeneration, and developmental disorders, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and structural biology continue to unravel its mechanisms, offering new opportunities for drug discovery.
References
- 1. Muli CS et al.. 2019. Small-Molecule Inhibitors of the Proteasome's Regulatory Particle.. Chembiochem 20(14):1739-1753 PMID: 30740849
- 2. Glickman MH et al.. 1999. Functional analysis of the proteasome regulatory particle.. Mol Biol Rep 26(1-2):21-8 PMID: 10363642
- 3. Park S et al.. 2010. Assembly manual for the proteasome regulatory particle: the first draft.. Biochem Soc Trans 38(Pt 1):6-13 PMID: 20074027
- 4. Lander GC et al.. 2013. The proteasome under the microscope: the regulatory particle in focus.. Curr Opin Struct Biol 23(2):243-51 PMID: 23498601
- 5. He L et al.. 2023. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.. Mol Cell 83(22):4000-4016.e6 PMID: 37935198
- 6. Dahlmann B. 2005. Proteasomes.. Essays Biochem 41:31-48 PMID: 16250896
- 7. Gu ZC et al.. 2014. Proteasome assembly.. Cell Mol Life Sci 71(24):4729-45 PMID: 25107634
- 8. Gao J et al.. 2025. Structure of the TXNL1-bound proteasome.. Nat Struct Mol Biol 32(12):2398-2402 PMID: 40770113
